Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis

Journal of Proteome Research

Volumn 13, Issue 4, 2014, Pages 1873-1884

  Nie, Song ^a   Lo, Andy ^a   Wu, Jing ^a   Zhu, Jianhui ^a   Tan, Zhijing ^a   Simeone, Diane M ^a   Anderson, Michelle A ^a   Shedden, Kerby A ^b   Ruffin, MacK T ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

ELISA; glycoprotein biomarker; pancreatic cancer; quantitative proteomics; serum; TMT protein level labeling

Indexed keywords

ALEURIA AURANTIA LECTIN; ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN A4; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C9; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; DNA DIRECTED RNA POLYMERASE; HAPTOGLOBIN; L SELECTIN; LECTIN; LUMICAN; N ACETYLMURAMOYLALANINE AMIDASE; PHOSPHOLIPID TRANSFER PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMA KALLIKREIN; PREALBUMIN; RAD50 PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; GLYCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PANCREAS CYST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN GLYCOSYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; VERY ELDERLY; BLOOD; MIDDLE AGED; PANCREAS TUMOR; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84898761999     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400967x     Document Type: Article

References (39)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009 Ca-Cancer J. Clin. 2009, 59 (4) 225-49
2. Chu, D.; Kohlmann, W.; Adler, D. G. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes JOP 2010, 11 (3) 203-12
3. Abraham, P.; Giannone, R. J.; Adams, R. M.; Kalluri, U.; Tuskan, G. A.; Hettich, R. L. Putting the Pieces Together: High-performance LC-MS/MS Provides Network-, Pathway-, and Protein-level Perspectives in Populus Mol. Cell. Proteomics 2012, 12 (1) 106-19
4. Sohn, T. A.; Lillemoe, K. D.; Cameron, J. L.; Huang, J. J.; Pitt, H. A.; Yeo, C. J. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s J. Am. Coll. Surg. 1999, 188 (6) 658-66 discussion 666-9.
5. Singh, P.; Srinivasan, R.; Wig, J. D. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment Pancreas 2011, 40 (5) 644-52
6. Pleskow, D. K.; Berger, H. J.; Gyves, J.; Allen, E.; McLean, A.; Podolsky, D. K. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer Ann. Intern. Med. 1989, 110 (9) 704-9
7. Partyka, K.; Maupin, K. A.; Brand, R. E.; Haab, B. B. Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation Proteomics 2012, 12 (13) 2212-20
8. Wehr, A. Y.; Hwang, W. T.; Blair, I. A.; Yu, K. H. Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry J. Proteome Res. 2012, 11 (3) 1749-58
9. Faca, V. M.; Song, K. S.; Wang, H.; Zhang, Q.; Krasnoselsky, A. L.; Newcomb, L. F.; Plentz, R. R.; Gurumurthy, S.; Redston, M. S.; Pitteri, S. J.; Pereira-Faca, S. R.; Ireton, R. C.; Katayama, H.; Glukhova, V.; Phanstiel, D.; Brenner, D. E.; Anderson, M. A.; Misek, D.; Scholler, N.; Urban, N. D.; Barnett, M. J.; Edelstein, C.; Goodman, G. E.; Thornquist, M. D.; McIntosh, M. W.; DePinho, R. A.; Bardeesy, N.; Hanash, S. M. A mouse to human search for plasma proteome changes associated with pancreatic tumor development PLoS Med. 2008, 5 (6) e123
10. Pan, S.; Chen, R.; Crispin, D. A.; May, D.; Stevens, T.; McIntosh, M. W.; Bronner, M. P.; Ziogas, A.; Anton-Culver, H.; Brentnall, T. A. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling J. Proteome Res. 2011, 10 (5) 2359-76
11. Bunger, S.; Laubert, T.; Roblick, U. J.; Habermann, J. K. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview J. Cancer Res. Clin. Oncol. 2011, 137 (3) 375-389
12. Wingren, C.; Sandstrom, A.; Segersvard, R.; Carlsson, A.; Andersson, R.; Lohr, M.; Borrebaeck, C. A. Identification of serum biomarker signatures associated with pancreatic cancer Cancer Res. 2012, 72 (10) 2481-90
13. Schiess, R.; Wollscheid, B.; Aebersold, R. Targeted proteomic strategy for clinical biomarker discovery Mol. Oncol. 2009, 3 (1) 33-44
14. Drake, P. M.; Cho, W.; Li, B.; Prakobphol, A.; Johansen, E.; Anderson, N. L.; Regnier, F. E.; Gibson, B. W.; Fisher, S. J. Sweetening the pot: adding glycosylation to the biomarker discovery equation Clin. Chem. 2010, 56 (2) 223-36
15. Liu, Y.; He, J.; Li, C.; Benitez, R.; Fu, S.; Marrero, J.; Lubman, D. M. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations J. Proteome Res. 2010, 9 (2) 798-805
16. Wu, J.; Xie, X.; Liu, Y.; He, J.; Benitez, R.; Buckanovich, R. J.; Lubman, D. M. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS J. Proteome Res. 2012, 11 (9) 4541-52
17. Kaur, S.; Baine, M. J.; Jain, M.; Sasson, A. R.; Batra, S. K. Early diagnosis of pancreatic cancer: challenges and new developments Biomarkers Med. 2012, 6 (5) 597-612
18. McKay, C. J.; Glen, P.; McMillan, D. C. Chronic inflammation and pancreatic cancer Best Pract. Res., Clin. Gastroenterol. 2008, 22 (1) 65-73
19. Ben, Q.; Xu, M.; Ning, X.; Liu, J.; Hong, S.; Huang, W.; Zhang, H.; Li, Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies Eur. J. Cancer 2011, 47 (13) 1928-37
20. Sener, S. F.; Fremgen, A.; Menck, H. R.; Winchester, D. P. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J. Am. Coll. Surg. 1999, 189 (1) 1-7
21. Nie, S.; Lo, A.; Zhu, J.; Wu, J.; Ruffin, M. T.; Lubman, D. M. Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry Anal. Chem. 2013, 85 (11) 5353-7
22. He, J.; Liu, Y.; Xie, X.; Zhu, T.; Soules, M.; DiMeco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach J. Proteome Res. 2010, 9 (5) 2565-72
23. Zhu, J.; He, J.; Liu, Y.; Simeone, D. M.; Lubman, D. M. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray J. Proteome Res. 2012, 11 (4) 2272-81
24. Lin, Z.; Simeone, D. M.; Anderson, M. A.; Brand, R. E.; Xie, X.; Shedden, K. A.; Ruffin, M. T.; Lubman, D. M. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer J. Proteome Res. 2011, 10 (5) 2602-11
25. Comunale, M. A.; Lowman, M.; Long, R. E.; Krakover, J.; Philip, R.; Seeholzer, S.; Evans, A. A.; Hann, H. W.; Block, T. M.; Mehta, A. S. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma J. Proteome Res. 2006, 5 (2) 308-15
26. Matsumoto, H.; Shinzaki, S.; Narisada, M.; Kawamoto, S.; Kuwamoto, K.; Moriwaki, K.; Kanke, F.; Satomura, S.; Kumada, T.; Miyoshi, E. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer Clin. Chem. Lab. Med. 2010, 48 (4) 505-12
27. Fanayan, S.; Hincapie, M.; Hancock, W. S. Using lectins to harvest the plasma/serum glycoproteome Electrophoresis 2012, 33 (12) 1746-54
28. Pan, S.; Chen, R.; Aebersold, R.; Brentnall, T. A. Mass spectrometry based glycoproteomics - from a proteomics perspective Mol. Cell. Proteomics 2011, 10 (1) R110 003251
29. Tu, C.; Rudnick, P. A.; Martinez, M. Y.; Cheek, K. L.; Stein, S. E.; Slebos, R. J.; Liebler, D. C. Depletion of abundant plasma proteins and limitations of plasma proteomics J. Proteome Res. 2010, 9 (10) 4982-91
30. Ueda, K.; Takami, S.; Saichi, N.; Daigo, Y.; Ishikawa, N.; Kohno, N.; Katsumata, M.; Yamane, A.; Ota, M.; Sato, T. A.; Nakamura, Y.; Nakagawa, H. Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes Mol. Cell. Proteomics 2010, 9 (9) 1819-28
31. Zhang, X.; Yin, X.; Yu, H.; Liu, X.; Yang, F.; Yao, J.; Jin, H.; Yang, P. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry Analyst 2012, 137 (2) 490-5
32. Collier, T. S.; Randall, S. M.; Sarkar, P.; Rao, B. M.; Dean, R. A.; Muddiman, D. C. Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression Rapid Commun. Mass Spectrom. 2011, 25 (17) 2524-32
33. Buxbaum, J. L.; Eloubeidi, M. A. Molecular and clinical markers of pancreas cancer JOP 2010, 11 (6) 536-44
34. Muniraj, T.; Chari, S. T. Diabetes and pancreatic cancer Minerva Dietol. Gastroenterol. 2012, 58 (4) 331-45
35. Tonack, S.; Jenkinson, C.; Cox, T.; Elliott, V.; Jenkins, R. E.; Kitteringham, N. R.; Greenhalf, W.; Shaw, V.; Michalski, C. W.; Friess, H.; Neoptolemos, J. P.; Costello, E. iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance Br. J. Cancer 2013, 108 (9) 1846-53
36. Lakatos, G.; Tulassay, Z. [The epidemiology of pancreatic cancer] Orv Hetil 2010, 151 (44) 1816-22
37. Wasan, H. S.; Springett, G. M.; Chodkiewicz, C.; Wong, R.; Maurel, J.; Barone, C.; Rosbrook, B.; Ricart, A. D.; Kim, S.; Spano, J. P. CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone Br. J. Cancer 2009, 101 (7) 1162-1167
38. Goh, K. L.; Yoon, B. K. Early detection of pancreatic cancer: a possibility in some cases but not a reality in most J. Dig. Dis. 2012, 13 (8) 389-92
39. Brentnall, T. A. Pancreatic cancer surveillance: learning as we go Am. J. Gastroenterol. 2011, 106 (5) 955-6